Kromek

KROMEK CELEBRATES 20TH ANNIVERSARY

24/05/2023

Kromek Group plc, the Sedgefield-based technology company, is celebrating its 20th year in business.

Established in 2003 as a spin out from Durham University, Kromek’s innovations in areas of detection and advanced imaging are providing lifesaving solutions for a safer and healthier world.

Now exporting to more than 50 countries around the globe, the organisation is fast becoming a world leader in areas of nuclear detection and is also providing diagnostic tools to help with the early discovery of debilitating diseases such as cancer.

Within its first ten years, the company had already secured contracts with the UK government, the United States Department of Defense and NASA, and officially listed on AIM, a market of the London Stock Exchange, in 2013.

During this period Kromek has been recognised for several prestigious accolades, including Global Security Challenge, Counter Terror Awards, UK Tech Awards, IP 100 and the Queen’s Award for Enterprise in recognition of its outstanding contribution to international trade.

More recently, Kromek’s world-leading technology has been used as a protection ring for the world’s most high-profile events including US president visits to NATO summits and critical infrastructures.

Dr Arnab Basu, CEO of Kromek Group plc, said: “We are delighted to be celebrating 20 years of Kromek. We’ve come a long way since we started life as Durham Scientific Crystals, from having operations in the UK to serving a global customer base. I’m incredibly proud of everything we’ve achieved on our journey so far.

“Our work has been recognised by many individuals and organisations from around the world, which included a recent visit from King Charles III, before his accession, to officially commission our cadmium zinc telluride (CZT) furnaces in 2020.

“We’ve got a fantastic team here who are always innovating and pushing the boundaries of what is possible within our areas of work. I’m incredibly grateful for everyone we’ve had working with us over the past two decades, because we’ve had some incredible talent.

“It was wonderful to celebrate the efforts of our teams with an outdoor picnic and activity session both in our UK and US facilities!”

ENDS

CONTACT: Alex Dryden 01325 363436

About Kromek Group plc

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.

The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer’s, contamination in industrial manufacture and explosives in aviation settings.

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek’s compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of ‘dirty bombs’.

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol ‘KMK’.

Further information is available at www.kromek.com.

back to Kromek

Images

The Kromek team pictured outside its Sedgefield headquarters
The Kromek team pictured outside its Sedgefield headquarters
Download Large Image
founding chair, Prof Brian Tanner (left) with CEO and founder Dr Arnab Basu, innovation director Dr Ben Cantwell and senior staff scientist Dr John Mullins
founding chair, Prof Brian Tanner (left) with CEO and founder Dr Arnab Basu, innovation director Dr Ben Cantwell and senior staff scientist Dr John Mullins
Download Large Image